Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions
- Christopher B. FoxAffiliated withInfectious Disease Research Institute Email author
- , Susan L. BaldwinAffiliated withInfectious Disease Research Institute
- , Malcolm S. DuthieAffiliated withInfectious Disease Research InstituteProtein Advances Inc.
- , Steven G. ReedAffiliated withInfectious Disease Research InstituteImmune Design Corp.
- , Thomas S. VedvickAffiliated withInfectious Disease Research Institute
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Egg phosphatidylcholine is commonly used as an emulsifier in formulations administered parenterally. However, synthetic phosphatidylcholine (PC) emulsifiers are now widely available and may be desirable substitutes for egg-derived phospholipids due to stability, purity, and material source considerations. In earlier work, we demonstrated that a squalene–1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) emulsion provided equivalent physical stability compared to a squalene–egg PC emulsion. In the present manuscript, we evaluate the physical stability of vaccine adjuvant emulsions containing a range of other synthetic phosphatidylcholine emulsifiers. Besides the POPC emulsion, the 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) emulsion showed good particle size and visual stability compared to emulsions made with other synthetic phospholipids. Moreover, comparable immune responses were elicited by squalene emulsions employing various synthetic PC or egg PC emulsifiers in combination with an inactivated influenza vaccine or a recombinant malaria antigen, and these responses were generally enhanced compared to antigen without adjuvant. Therefore, we show that (1) some synthetic PCs (DMPC, POPC, and to a lesser extent 1,2-dioleoyl-sn-glycero-3-phosphocholine) are effective stabilizers of squalene emulsion over a range of storage temperatures while others are not (1,2-distearoyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, and 1,2-dilauroyl-sn-glycero-3-phosphocholine) and (2) the immunogenicity of stable squalene emulsions is similar regardless of PC source.
Key wordsoil-in-water emulsion phosphatidylcholine squalene vaccine adjuvant
- Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions
Volume 13, Issue 2 , pp 498-506
- Cover Date
- Online ISSN
- Springer US
- Additional Links
- oil-in-water emulsion
- vaccine adjuvant
- Industry Sectors
- Author Affiliations
- 1. Infectious Disease Research Institute, 1124 Columbia St, Ste 400, Seattle, Washington, 98104, USA
- 2. Protein Advances Inc., 1102 Columbia St, Ste 110, Seattle, Washington, 98104, USA
- 3. Immune Design Corp., 1124 Columbia St, Ste 700, Seattle, Washington, 98104, USA